Skip to content

Omission of axillary lymph node dissection in patients with clinically negative but pathologically positive sentinel-node metastasis

Omission of axillary lymph node dissection in patients with clinically negative but pathologically positive sentinel-node metastasis - JFCR B-01

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013059
Enrollment
650
Registered
2014-03-01
Start date
2014-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinically node negative breast cancer patient

Interventions

None listed

Sponsors

Division of Breast Surgery, Cancer Institute Hospital of Japanese Foudation for Cancer Reaserch
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Breast cancer is diagnosed histologically 2)Tis,T1-T3,N0,M0 3)Age: 20 years old or older 4)Perfromance status: 0 or 1 5)Function of the main organs are good condition 6)By an explanation document, the agreements from a patient to a trial entry are provided

Exclusion criteria

Exclusion criteria: 1)Ipsilateral breast tumor recurrence 2)Not prior neoadjuvant chemotherapy 3)Not pregnant or nursing 4)The patient who does not receive the the medicine 5)Examination participation of the patient is taken as inappropriate by the medical attendant

Design outcomes

Primary

MeasureTime frame
Distant disease-free survival

Secondary

MeasureTime frame
Axillary lymph node recurrence rate Overall survival

Countries

Japan

Contacts

Public ContactUta Nakadaira

Cancer Institute Hospital of Japanese Foudation for Cancer Reaserch Breast Surgery

uta.nakadaira@jfcr.or.jp03-3520-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026